Evidence map›Paper›PMID 31836681›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

Histologically Confirmed Diagnostic Efficacy of

Markus Kroenke, Alexander Wurzer, Kristina Schwamborn, Lena Ulbrich, Lena Jooß, Tobias Maurer, Thomas Horn, Isabel Rauscher, Bernhard Haller, Michael Herz and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05622162 (Phase III Multicentre Prospective Comparative Study of Detection Rate of 18F-JK-PSMA-7 and of 18F-fluorocholine in Patients With Biochemical Recurrence of Prostate Cancer After Previous Treatment With Curative Intent), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05622162 phase3unknown statusnot on this mapstarted 2022, after this paper: background citation

Phase III Multicentre Prospective Comparative Study of Detection Rate of 18F-JK-PSMA-7 and of 18F-fluorocholine in Patients With Biochemical Recurrence of Prostate Cancer After Previous Treatment With Curative Intent

TypeinterventionalSponsorITEL Telecomunicazioni SrlRan2022 to 2024Enrolled106ConditionsProstate Cancer, 18F- Fluorocholine, PSMA PET, RadiotherapyArmsRadiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Radiology. Imaging cancer · 2022
    Pooled it
  2. Safety, Biodistribution, and Radiation Dosimetry ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Trial
  3. International journal of clinical oncology · 2026
    Article
  4. Influence of fasting prior toEJNMMI research · 2024
    Article
  5. Review
  6. Validation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  7. Article
  8. Synthesis and Preclinical Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  9. Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  10. Review
  11. Pretherapeutic Comparative Dosimetry ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  12. Article
  13. Article
  14. Kinetic analysis and optimisation ofEuropean journal of nuclear medicine and molecular imaging · 2021
    Article
  15. Prospective comparison ofEuropean journal of nuclear medicine and molecular imaging · 2021
    Article
  16. Review
  17. Diagnostic Accuracy ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  18. Automated synthesis of [EJNMMI radiopharmacy and chemistry · 2021
    Article
  19. Preclinical comparison of four [EJNMMI research · 2020
    Article
  20. Radiohybrid Ligands: A Novel Tracer Concept Exemplified byJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Markus KroenkeDepartment of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Alexander WurzerTechnical University of Munich, Munich, Germany.
Kristina SchwambornInstitute of Pathology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Lena UlbrichDepartment of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Lena JooßDepartment of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Tobias MaurerMartini-Klinik and Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Thomas HornDepartment of Urology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; and.
Isabel RauscherDepartment of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Bernhard HallerInstitute of Medical Informatics, Statistics and Epidemiology, School of Medicine, Technical University of Munich, Munich, Germany.
Michael HerzDepartment of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Hans-Jürgen WesterTechnical University of Munich, Munich, Germany.
Wolfgang A WeberDepartment of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Matthias EiberDepartment of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany matthias.eiber@tum.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GlutaratesPhosphinic AcidsPositron-Emission TomographyAgedAged, 80 and overHumansMaleMiddle AgedNeoplasm StagingProstatic NeoplasmsRetrospective StudiesRisk(18)F-PSMA-11GlutaratesPhosphinic Acidshybrid imaginglymph nodesN-stagingPETprostate cancerprostate-specific membrane antigen (PSMA)

Identifiers

PMID31836681
PMCPMC7198390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.